Effect of Pollen-Specific Sublingual Immunotherapy on Oral Allergy Syndrome by Karl-Christian Bergmann, MD, Hendrik Wolf, PhD, Jörg Schnitker, PhD

Get full text

Extension of mepolizumab injection intervals as potential of saving costs in well controlled patients with severe eosinophilic asthma by Georg Bölke, MD, Xunliang Tong, MD, Torsten Zuberbier, MD, PhD, Jean Bousquet, MD, PhD, Karl-Christian Bergmann, MD, PhD

Get full text

A real-life comparison of pulmonary and nasal outcomes in patients with severe asthma and nasal polyposis treated with T2-biologics by Ulrike Förster-Ruhrmann, MD, Dafni Stergioudi, MD, Agnieszka J. Szczepek, PhD, Joachim W. Fluhr, MD, PhD, Torsten Zuberbier, MD, PhD, Heidi Olze, MD, PhD, Karl-Christian Bergmann, MD, PhD

Get full text

Safety of 300IR house dust mite sublingual tablet from pooled clinical trial and post-marketing data by Margitta Worm, MD, Pascal Demoly, MD, PhD, Yoshitaka Okamoto, MD, PhD, Carmen Vidal, MD, PhD, Katia Daghildjian, PharmD, PhD, Kwok Yan, MD, Thomas B. Casale, MD, Karl-Christian Bergmann, MD, PhD

Get full text

Initiation, response assessment, and switch of antibody therapies in patients with severe asthma – A survey among German specialists by Hendrik Suhling, MD, Dirk Skowasch, MD, Karl-Christian Bergmann, MD, Carlo Mümmler, MD, Roland Buhl, MD, Rainer Ehmann, Eckard Hamelmann, MD, Marco Idzko, MD, Margret Jandl, Christian Schulz, Olaf Schmidt, Christian Taube, MD, Stephanie Korn, MD, Katrin Milger, MD

Get full text